Glia · 2019 · 33 citations · 80 references
Life SciencesImmunologyNeuroscienceImmunopathologyInflammationNeuroimmunologyBlood-brain Barrier BiologyBlood-brain Barrier DysfunctionComplement SystemNeuroinflammationNeurovascular DysfunctionPlasma ProteinsBlood-brain Barrier PathologyBlood-brain Barrier PermeabilityC1 InhibitorComplement System ActivationNeurovascular InflammationNeurovascular Unit DysfunctionNeurovascular Unit InjuryNeurovascular Unit Signaling
The cross-talk between blood proteins, immune cells, and brain function involves complex mechanisms. Plasma protein C1 inhibitor (C1INH) is an inhibitor of vascular inflammation that is induced by activation of the kallikrein-kinin system (KKS) and the complement system. Knockout of C1INH was previously correlated with peripheral vascular permeability via the bradykinin pathway, yet there was no evidence of its correlation with blood-brain barrier (BBB) integrity and brain function. In order to understand the effect of plasma C1INH on brain pathology via the vascular system, we knocked down circulating C1INH in wild-type (WT) mice using an antisense oligonucleotide (ASO), without affecting C1INH expression in peripheral immune cells or the brain, and examined brain pathology. Long-term elimination of endogenous C1INH in the plasma induced the activation of the KKS and peritoneal macrophages but did not activate the complement system. Bradykinin pathway proteins were elevated in the periphery and the brain, resulting in hypotension. BBB permeability, extravasation of plasma proteins into the brain parenchyma, activation of glial cells, and elevation of pro-inflammatory response mediators were detected. Furthermore, infiltrating innate immune cells were observed entering the brain through the lateral ventricle walls and the neurovascular unit. Mice showed normal locomotion function, yet cognition was impaired and depressive-like behavior was evident. In conclusion, our results highlight the important role of regulated plasma C1INH as it acts as a gatekeeper to the brain via the neurovascular system. Thus, manipulation of C1INH in neurovascular disorders might be therapeutically beneficial.
80
Fate Mapping Analysis Reveals That Adult Microglia Derive from Primitive Macrophages
Florent Ginhoux, Melanie Greter, Marylène Leboeuf et al. · Science · 2010 · 5.1K citations · Full text
Plasma bradykinin in angio-oedema
Juerg Nussberger, Massimo Cugno, C Amstutz et al. · The Lancet · 1998 · 704 citations
Hereditary and Acquired C1-Inhibitor Deficiency
A Agostoni, Marco Cicardi · Medicine · 1992 · 612 citations
Life Sciences, Genetics, Immunology +13
TMEM119 marks a subset of microglia in the human brain
Jun‐ichi Satoh, Yoshihiro Kino, Naohiro Asahina et al. · Neuropathology · 2015 · 448 citations